UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers

Molecular cancer research, 2018-05, Vol.16 (5), p.805-812

2018

Volltextzugriff (PDF)

Relationship between MLH1, PMS2, MSH2 and MSH6 gene‐specific alterations and tumor mutational burden in 1057 microsatellite instability‐high solid tumors

International journal of cancer, 2020-11, Vol.147 (10), p.2948-2956

2020

Volltextzugriff (PDF)

Imaging of Cell Proliferation: Status and Prospects

Journal of Nuclear Medicine, 2008-06, Vol.49 (Suppl_2), p.64S-80S

2008

Volltextzugriff (PDF)

A new prognostic and predictive tool for shared decision making in stage III colon cancer

European journal of cancer (1990), 2020-10, Vol.138, p.182-188

2020

Volltextzugriff (PDF)

Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2

Proceedings of the National Academy of Sciences - PNAS, 2013-07, Vol.110 (27), p.11199-11204

2013

Volltextzugriff (PDF)

Physical Activity in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance)

Journal of clinical oncology, 2023-01, Vol.41 (2), p.243-254

2023

Volltextzugriff (PDF)

Impact of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography (PET) Alone on Expected Management of Patients With Cancer: Initial Results From the National Oncologic PET Registry

Journal of clinical oncology, 2008-05, Vol.26 (13), p.2155-2161

2008

Volltextzugriff (PDF)

The impact of ARID1A mutation on molecular characteristics in colorectal cancer

European journal of cancer (1990), 2020-11, Vol.140, p.119-129

2020

Volltextzugriff (PDF)

Clinical Validation of a Machine-learning-derived Signature Predictive of Outcomes from First-line Oxaliplatin-based Chemotherapy in Advanced Colorectal Cancer

Clinical cancer research, 2021-02, Vol.27 (4), p.1174-1183

2021

Volltextzugriff (PDF)

Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer

Clinical cancer research, 2022-05, Vol.28 (9), p.1863-1870

2022

Volltextzugriff (PDF)

Clinical and immune responses to anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (EGFR BATs) in pancreatic cancer patients

Oncoimmunology, 2020-01, Vol.9 (1), p.1773201-1773201

2020

Volltextzugriff (PDF)

Relationship Between Cancer Type and Impact of PET and PET/CT on Intended Management: Findings of the National Oncologic PET Registry

Journal of Nuclear Medicine, 2008-12, Vol.49 (12), p.1928-1935

2008

Volltextzugriff (PDF)

Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials

The Journal of nuclear medicine (1978), 2015-08, Vol.56 (8), p.1137-1143

2015

Volltextzugriff (PDF)

Molecular profile of BRCA-mutated biliary tract cancers

ESMO open, 2020-06, Vol.5 (3), p.e000682-e000682, Article e000682

2020

Volltextzugriff (PDF)

Positron emission tomography measurement of tumor metabolism and growth: its expanding role in oncology

Molecular imaging and biology, 2006-05, Vol.8 (3), p.141-150

Shields, Anthony F

2006

Volltextzugriff (PDF)

Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors

Journal for immunotherapy of cancer, 2021-07, Vol.9 (7), p.e003019

2021

Volltextzugriff (PDF)

Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells

Journal for immunotherapy of cancer, 2024-03, Vol.12 (3), p.e008744

2024

Volltextzugriff (PDF)

Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer

JNCI cancer spectrum, 2020-06, Vol.4 (3), p.pkaa023-pkaa023

2020

Volltextzugriff (PDF)

Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer

International journal of radiation oncology, biology, physics, 2004-06, Vol.59 (2), p.454-459

2004

Volltextzugriff (PDF)

Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer

NPJ precision oncology, 2024-09, Vol.8 (1), p.214-10, Article 214

2024

Volltextzugriff (PDF)

Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313

Journal of clinical oncology, 2019-05, Vol.37 (13), p.1062-1069

2019

Volltextzugriff (PDF)

Molecular analysis of XPO1 inhibitor and gemcitabine–nab‐paclitaxel combination in KPC pancreatic cancer mouse model

Clinical and translational medicine, 2023-12, Vol.13 (12), p.e1513-n/a

2023

Volltextzugriff (PDF)

The Effects of Oncologist Implicit Racial Bias in Racially Discordant Oncology Interactions

Journal of clinical oncology, 2016-08, Vol.34 (24), p.2874-2880

2016

Volltextzugriff (PDF)

The current state of molecular testing in the treatment of patients with solid tumors, 2019

CA: a cancer journal for clinicians, 2019-07, Vol.69 (4), p.305-343

2019

Volltextzugriff (PDF)

Preferences and Attitudes of Cardiologists in Management of Patients with Cancer

Palliative medicine reports, 2022-11, Vol.3 (1), p.279-286

2022

Volltextzugriff (PDF)

1 – 25 von 375

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(342)
Mit Volltextzugriff
(318)

Publikationsform

Sprache

Englisch
(375)

Erscheinungsjahr

n.n

Thema

Science & Technology
(218)
Life Sciences & Biomedicine
(203)
Humans
(178)
Oncology
(138)
Male
(111)
Female
(104)
Middle Aged
(92)
Aged
(85)
Adult
(69)
Biological And Medical Sciences
(56)
Medical Sciences
(53)
Tumors
(51)
Cancer
(45)
Aged, 80 And Over
(43)
Radiology, Nuclear Medicine & Medical Imaging
(43)
Patients
(38)
Chemotherapy
(36)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(33)
Animals
(31)
Treatment Outcome
(31)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers

Relationship between MLH1, PMS2, MSH2 and MSH6 gene‐specific alterations and tumor mutational burden in 1057 microsatellite instability‐high solid tumors

Imaging of Cell Proliferation: Status and Prospects

A new prognostic and predictive tool for shared decision making in stage III colon cancer

Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2

Physical Activity in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance)

Impact of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography (PET) Alone on Expected Management of Patients With Cancer: Initial Results From the National Oncologic PET Registry

The impact of ARID1A mutation on molecular characteristics in colorectal cancer

Clinical Validation of a Machine-learning-derived Signature Predictive of Outcomes from First-line Oxaliplatin-based Chemotherapy in Advanced Colorectal Cancer

Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer

Clinical and immune responses to anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (EGFR BATs) in pancreatic cancer patients

Relationship Between Cancer Type and Impact of PET and PET/CT on Intended Management: Findings of the National Oncologic PET Registry

Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials

Molecular profile of BRCA-mutated biliary tract cancers

Positron emission tomography measurement of tumor metabolism and growth: its expanding role in oncology

Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors

Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells

Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer

Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer

Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer

Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313

Molecular analysis of XPO1 inhibitor and gemcitabine–nab‐paclitaxel combination in KPC pancreatic cancer mouse model

The Effects of Oncologist Implicit Racial Bias in Racially Discordant Oncology Interactions

The current state of molecular testing in the treatment of patients with solid tumors, 2019

Preferences and Attitudes of Cardiologists in Management of Patients with Cancer

Suchergebnisse filtern